Twist Bioscience (TWST) Finished Goods (2018 - 2026)

Twist Bioscience has disclosed Finished Goods across 9 years of filings, most recently posting $5.0 million for Q1 2026.

• In Q1 2026, Finished Goods changed 0.06% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed 0.06% YoY), while the FY2025 annual figure was $5.9 million, up 26.8% from the prior year.
• Finished Goods declined to $5.0 million in Q1 2026, from $5.9 million in the prior quarter.
• Over the last five years, Finished Goods for TWST reached as high as $9.6 million in Q1 2022 and fell as low as $3.9 million in Q3 2023.
• The 5-year median for Finished Goods is $5.3 million (2023), against an average of $5.9 million.
• Annual changes were most pronounced in 2022 — Finished Goods jumped 415.24% — and 2023, when it sank 48.71%.
• A 5-year view of Finished Goods shows it stood at $7.4 million in 2022, then slumped by 36.47% to $4.7 million in 2023, then gained by 2.75% to $4.8 million in 2024, then rose by 22.43% to $5.9 million in 2025, then decreased by 15.41% to $5.0 million in 2026.
• According to Business Quant data, Finished Goods over the past three periods registered $5.0 million, $5.9 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.